Durable Response to Immune Checkpoint Blockade in a Platinum-Refractory Patient With Nonseminomatous Germ Cell Tumor

被引：31

作者：

Chi, Ethan A. ^{[1
]}

Schweizer, Michael T. ^{[1
]}

机构：

[1] Univ Washington, Fred Hutchinson Canc Res Ctr, Dept Med, Div Oncol, Seattle, WA 98109 USA

来源：

CLINICAL GENITOURINARY CANCER | 2017年 / 15卷 / 05期

关键词：

Anti-PD1; Anti-PDL1; Immunotherapy; Nivolumab; Testicular cancer; HIGH-DOSE CHEMOTHERAPY; TESTICULAR-CANCER; PD-1; BLOCKADE; LUNG-CANCER; PHASE-II; CISPLATIN; OXALIPLATIN; GEMCITABINE; IFOSFAMIDE; NIVOLUMAB;

D O I：

10.1016/j.clgc.2017.04.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Some germ cell tumors might respond favorably to immune checkpoint blockade. Clinical trials to test immunotherapeutic approaches in chemorefractory germ cell tumors are warranted. (C) 2017 Elsevier Inc. All rights reserved.

引用

页码：E855 / E857

页数：3

共 20 条

[1] PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma [J].

Ansell, Stephen M. ;

Lesokhin, Alexander M. ;

Borrello, Ivan ;

Halwani, Ahmad ;

Scott, Emma C. ;

Gutierrez, Martin ;

Schuster, Stephen J. ;

Millenson, Michael M. ;

Cattry, Deepika ;

Freeman, Gordon J. ;

Rodig, Scott J. ;

Chapuy, Bjoern ;

Ligon, Azra H. ;

Zhu, Lili ;

Grosso, Joseph F. ;

Kim, Su Young ;

Timmerman, John M. ;

Shipp, Margaret A. ;

Armand, Philippe .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :311-319

[2] Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer [J].

Brahmer, Julie ;

Reckamp, Karen L. ;

Baas, Paul ;

Crino, Lucio ;

Eberhardt, Wilfried E. E. ;

Poddubskaya, Elena ;

Antonia, Scott ;

Pluzanski, Adam ;

Vokes, Everett E. ;

Holgado, Esther ;

Waterhouse, David ;

Ready, Neal ;

Gainor, Justin ;

Aren Frontera, Osvaldo ;

Havel, Libor ;

Steins, Martin ;

Garassino, Marina C. ;

Aerts, Joachim G. ;

Domine, Manuel ;

Paz-Ares, Luis ;

Reck, Martin ;

Baudelet, Christine ;

Harbison, Christopher T. ;

Lestini, Brian ;

Spigel, David R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) :123-135

[3] Phase II study of oxaliplatin and gemcitabine salvage chemotherapy in patients with cisplatin-refractory nonseminomatous germ cell tumor [J].

De Giorgi, Ugo ;

Rosti, Giovanni ;

Aieta, Michele ;

Testore, Franco ;

Burattini, Luciano ;

Fornarini, Giuseppe ;

Naglieri, Emanuele ;

Lo Re, Giovanni ;

Zumaglini, Federica ;

Marangolo, Maurizio .

EUROPEAN UROLOGY, 2006, 50 (05) :1032-1039

[4] High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors [J].

Einhorn, Lawrence H. ;

Williams, Stephen D. ;

Chamness, Amy ;

Brames, Mary J. ;

Perkins, Susan M. ;

Abonour, Rafat .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (04) :340-348

[5] Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer [J].

Garon, Edward B. ;

Rizvi, Naiyer A. ;

Hui, Rina ;

Leighl, Natasha ;

Balmanoukian, Ani S. ;

Eder, Joseph Paul ;

Patnaik, Amita ;

Aggarwal, Charu ;

Gubens, Matthew ;

Horn, Leora ;

Carcereny, Enric ;

Ahn, Myung-Ju ;

Felip, Enriqueta ;

Lee, Jong-Seok ;

Hellmann, Matthew D. ;

Hamid, Omid ;

Goldman, Jonathan W. ;

Soria, Jean-Charles ;

Dolled-Filhart, Marisa ;

Rutledge, Ruth Z. ;

Zhang, Jin ;

Lunceford, Jared K. ;

Rangwala, Reshma ;

Lubiniecki, Gregory M. ;

Roach, Charlotte ;

Emancipator, Kenneth ;

Gandhi, Leena .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (21) :2018-2028

[6] Testicular Cancer - Discoveries and Updates [J].

Hanna, Nasser H. ;

Einhorn, Lawrence H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (21) :2005-2016

[7] Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: A study of the German Testicular Cancer Study Group [J].

Kollmannsberger, C ;

Beyer, J ;

Liersch, R ;

Schoeffski, P ;

Metzner, B ;

Rick, O ;

Hartmann, JT ;

Stengele, K ;

Hohloch, K ;

Spott, C ;

Kanz, L ;

Bokemeyer, C .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) :108-114

[8] Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors [J].

Kondagunta, GV ;

Bacik, J ;

Donadio, A ;

Bajorin, D ;

Marion, S ;

Sheinfeld, J ;

Bosl, GJ ;

Motzer, RJ .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) :6549-6555

[9] PD-1 Blockade in Tumors with Mismatch-Repair Deficiency [J].

Le, D. T. ;

Uram, J. N. ;

Wang, H. ;

Bartlett, B. R. ;

Kemberling, H. ;

Eyring, A. D. ;

Skora, A. D. ;

Luber, B. S. ;

Azad, N. S. ;

Laheru, D. ;

Biedrzycki, B. ;

Donehower, R. C. ;

Zaheer, A. ;

Fisher, G. A. ;

Crocenzi, T. S. ;

Lee, J. J. ;

Duffy, S. M. ;

Goldberg, R. M. ;

de la Chapelle, A. ;

Koshiji, M. ;

Bhaijee, F. ;

Huebner, T. ;

Hruban, R. H. ;

Wood, L. D. ;

Cuka, N. ;

Pardoll, D. M. ;

Papadopoulos, N. ;

Kinzler, K. W. ;

Zhou, S. ;

Cornish, T. C. ;

Taube, J. M. ;

Anders, R. A. ;

Eshleman, J. R. ;

Vogelstein, B. ;

Diaz, L. A., Jr. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (26) :2509-2520

[10] SALVAGE THERAPY IN RECURRENT GERM-CELL CANCER - IFOSFAMIDE AND CISPLATIN PLUS EITHER VINBLASTINE OR ETOPOSIDE [J].

LOEHRER, PJ ;

LAUER, R ;

ROTH, BJ ;

WILLIAMS, SD ;

KALASINSKI, LA ;

EINHORN, LH .

ANNALS OF INTERNAL MEDICINE, 1988, 109 (07) :540-546

← 1 2 →